Abstract
BackgroundIntra-articular local anesthetics are widely used for diagnostic analgesia in horses, but their effects on lameness and the synovial environment may differ between drugs.Aims/objectiveso compare clinical efficacy and synovial fluid biochemical response after intra-articular administration of mepivacaine and ropivacaine in horses.MethodsIn a prospective study, 24 middle carpal joints from 12 clinically healthy horses were evaluated for synovial fluid total protein and lactate dehydrogenase activity before and 24 h after administration of mepivacaine 3% (100 mg) or ropivacaine 1% (40 mg), each diluted with 0.9% saline to a final volume of 5 mL. The same doses were used in a second randomized crossover experiment involving eight horses with naturally occurring tarsal joint-related lameness, with clinical efficacy assessed by objective inertial-sensor gait analysis from baseline to 240 min.ResultsObjective lameness values changed over time (P < 0.001), with no treatment effect (P = 0.620) or treatment-by-time interaction (P = 0.409). Mean clinical improvement approached 70% for both treatments at 10 min. At 240 min, improvement was approximately 86% after ropivacaine and 46% after mepivacaine; however, this was descriptive because the treatment-by-time interaction was not significant. At 24 h, total protein was 2.16 g/dL after ropivacaine and 3.42 g/dL after mepivacaine (P < 0.001). Lactate dehydrogenase activity was lower after ropivacaine than mepivacaine (513 vs. 991 U/L; P = 0.012).ConclusionUnder the conditions studied, ropivacaine produced a clinical response comparable to mepivacaine while being associated with smaller acute changes in the evaluated synovial fluid biomarkers.